RESUMEN
Patients in the chronic phase of Chagas' disease and receiving corticoid because of concommitant diseases were treated with benznidazole, which was initiated at the same time of the use of corticoid in a group of 12 patients or 15 days afterwards in 6 patients. It has been proved in another paper that in the chronic phase of Chagas' disease corticoid use is associated with increased parasitemia, as evaluated by xenodiagnosis. In this study benznidazole use prevented this increase, and we suggest that in immunocompromised patients with chronic Chagas' disease the use of this drug could be useful.
Asunto(s)
Enfermedad de Chagas/tratamiento farmacológico , Glucocorticoides/farmacología , Nitroimidazoles/uso terapéutico , Tripanocidas/uso terapéutico , Trypanosoma/efectos de los fármacos , Adolescente , Adulto , Animales , Enfermedad de Chagas/complicaciones , Enfermedad Crónica , Femenino , Glucocorticoides/efectos adversos , Humanos , Masculino , Persona de Mediana Edad , Trypanosoma/crecimiento & desarrolloRESUMEN
Patients in the chronic phase of Chagas' disease and receiving corticoid because of concommitant diseases were treated with nifurtimox. We proved in another paper that in the chronic phase of Chagas' disease corticoid use is associated with increased parasitemia, as evaluated by xenodiagnosis. In this study nifurtimox use prevented this increase, and we suggest that in immunocompromised patients with chronic Chagas' disease the use of this drug could be useful.
Asunto(s)
Antiparasitarios/uso terapéutico , Enfermedad de Chagas/tratamiento farmacológico , Glucocorticoides/uso terapéutico , Nifurtimox/uso terapéutico , Adulto , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Patients with chronic Chagas' disease and simultaneous medical problems treated with corticosteroid were studied in order to evaluate steroid influence on chronic Trypanosoma cruzi infection. Parasitological assessment, radiological and electrocardiographic studies as well as non specific tests were performed in patients and in a control group that included chronic infected patients not treated with steroid. Xenodiagnosis showed a clear increase in T. cruzi parasitemia, related to the corticosteroid dosage, without clinical manifestations during the study follow-up period.
Asunto(s)
Corticoesteroides/uso terapéutico , Enfermedad de Chagas , Adulto , Anciano , Animales , Enfermedad de Chagas/complicaciones , Enfermedad de Chagas/parasitología , Enfermedad Crónica , Femenino , Corazón/efectos de los fármacos , Humanos , Inmunosupresores/uso terapéutico , Masculino , Ratones , Persona de Mediana Edad , Prednisona/uso terapéutico , Trypanosoma cruzi/efectos de los fármacos , Trypanosoma cruzi/aislamiento & purificaciónRESUMEN
A group of rats was infected by the Y strain of T. cruzi and three animals were bled daily from the 4th to the 13th days. The sera obtained each day, after being mixed, were used for dosing serum complement and for acting as antigens in the CFT with a Chagas' disease serum. The amount of circulating antigen increased gradually, reached a maximum in the 5th and 6th days and then decreased up to the 10th day; thereafter it increased attaining a new maximum in the 11th day and again decreased up to the 13th day. The dosage of the complement showed that the 50 per cent unit was about 70 x 10(-4) in the first few days of the infection, reached 130 -- 135 x 10(-4) in the 7th and 8th days, and was back again to the initial levels in the 13th day. These results suggest a relation between the circulation of antigens, the formation of antigen antibody complexes, and the fixation of the complement by such complexes.
Asunto(s)
Antígenos/inmunología , Enfermedad de Chagas/inmunología , Proteínas del Sistema Complemento , Trypanosoma cruzi/inmunología , Animales , Formación de Anticuerpos , Pruebas de Fijación del Complemento , RatasRESUMEN
From rats infected with the Y strain of T. cruzi trypomastigotes were recovered in successive days to be used in agglutination tests (AT) and in direct immunofluorescence tests (DIT). Titres obtained in AT reached 1/640 with trypomastigotes in the fourth and fifth days, decreased to 1/160 in the sixth day and were negative in the seventh day; in the tenth day the titers were again up to 1/40 and reached 1/320 in the eleventh day. The DIT were negative with trypomastigotes in the fourth and fifth days, a few were positive in the sixth day and numerous were positive in the seventh day; again a few were positive in the tenth day and all were negative in the eleventh day. These results seems to indicate that the trypomastigotes are blocked by circulating antibodies when they are not agglutinated by immune sera in vitro.